The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus

INTRODUCTION: ENDURE (ClinicalTrials.gov identifier, NCT00856284), a multicenter, double-blind, active-controlled study of 2639 patients with uncontrolled type 2 diabetes mellitus (T2DM), found that metformin in combination with alogliptin (12.5 and 25 mg doses), when compared to standard add-on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Jason, McEwan, Phil, Hurst, Michael, Puelles, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118244/
https://www.ncbi.nlm.nih.gov/pubmed/27787778
http://dx.doi.org/10.1007/s13300-016-0206-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118244/
https://www.ncbi.nlm.nih.gov/pubmed/27787778
http://dx.doi.org/10.1007/s13300-016-0206-7

Ejemplares similares